Advertisement
Home Blog Page 3585
The first generic version of Nexium (esomeprazole magnesium delayed-release capsules) has been approved by the U.S. Food and Drug Administration to treat gastroesophageal reflux disease in adults and children ages 1 and older.

FDA Approves Generic Form of Nexium

0
To treat gastroesophageal reflux disease in adults and children ages 1 and older
Pain management treatment decisions may be impacted by a health care provider's demographic characteristics

Provider Demographics Affect Pain Treatment Decisions

0
These effects may contribute to pain management disparities
Dipeptidyl peptidase-4 inhibition may attenuate hepatic steatosis and insulin resistance induced by the Western diet through hepatic lipid remodeling and modulation of hepatic mitochondrial function

How Does DPP-4 Inhibition Affect Liver Function?

0
Mechanisms may involve hepatic lipid remodeling and modulation of hepatic mitochondrial function
The positive rate of the glucose breath test is higher in patients with inflammatory bowel disease

Glucose Breath Test Positivity Up in Inflammatory Bowel Disease

0
Positive rate significantly higher in patients with Crohn's disease; positivity linked to GI symptom
Intensive lifestyle modifications

Impact of Intensive Lifestyle Change on CV Burden Studied

0
Review indicates diet, exercise decrease overall coronary/carotid atherosclerosis burden
Natpara (parathyroid hormone) has been approved by the U.S. Food and Drug Administration to control hypocalcemia among people with hypoparathyroidism.

Natpara OK’d to Treat Low Blood Calcium in Hypoparathyroidism

0
Medication recommended for use in patients for whom the potential benefits outweigh potential risk
Childhood neglect is associated with changes in the brain's white matter

Childhood Neglect Appears to Affect White Matter Integrity

0
Changes less significant in children placed in high-quality foster care at an early age
The Bexsero vaccine has been approved by the U.S. Food and Drug Administration to prevent serogroup B meningococcal disease among people aged 10 through 25.

FDA Approves New Meningococcal Disease Vaccine

0
Bexsero is the second vaccine approved in the past three months to prevent this disease
Most primary care providers consider advanced medical imaging to be of considerable value for patient care

Most PCPs Consider Advanced Imaging of Value to Patient Care

0
Docs whose careers predate proliferation of imaging assign higher value to advanced imaging
Two studies published in the January/February issue of the Annals of Family Medicine evaluate the tools available for diagnosis of chronic obstructive pulmonary disease.

Studies Highlight Tools for Diagnosis of COPD

0
Tools include FEV1/FVC and laryngeal height plus Lung Function Questionnaire